V. R. Chandran

557 total citations
9 papers, 429 citations indexed

About

V. R. Chandran is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, V. R. Chandran has authored 9 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in V. R. Chandran's work include RNA regulation and disease (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Nuclear Receptors and Signaling (5 papers). V. R. Chandran is often cited by papers focused on RNA regulation and disease (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Nuclear Receptors and Signaling (5 papers). V. R. Chandran collaborates with scholars based in Singapore, Netherlands and Brazil. V. R. Chandran's co-authors include Pavanni Ratnagopal, Y. Yih, Eng‐King Tan, Yi Zhao, Hui Shen, Mei Lin Teoh, Martin C. S. Wong, Celia Ia Choo Tan, Stephanie Fook‐Chong and Henry Chung and has published in prestigious journals such as Neurology, Movement Disorders and Journal of the Neurological Sciences.

In The Last Decade

V. R. Chandran

9 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. R. Chandran Singapore 9 221 163 110 52 52 9 429
Daniel Hernández-Baltazar Mexico 8 163 0.7× 196 1.2× 116 1.1× 79 1.5× 15 0.3× 19 406
Meysam Hassani Moghaddam Iran 10 83 0.4× 76 0.5× 144 1.3× 89 1.7× 16 0.3× 39 413
Chrysoula Marogianni Greece 9 200 0.9× 98 0.6× 137 1.2× 134 2.6× 15 0.3× 18 452
Min Cai China 9 67 0.3× 97 0.6× 92 0.8× 38 0.7× 17 0.3× 23 353
S Ohara Japan 5 229 1.0× 197 1.2× 88 0.8× 57 1.1× 11 0.2× 7 402
Laura Montero United States 7 192 0.9× 227 1.4× 148 1.3× 78 1.5× 37 0.7× 7 491
Yuen Yih Singapore 12 431 2.0× 163 1.0× 126 1.1× 180 3.5× 32 0.6× 13 507
Martin T. Henrich Germany 11 269 1.2× 158 1.0× 100 0.9× 59 1.1× 8 0.2× 14 425
Celia van der Merwe South Africa 11 148 0.7× 93 0.6× 125 1.1× 30 0.6× 58 1.1× 16 371
Syed Imam United States 4 98 0.4× 94 0.6× 103 0.9× 31 0.6× 6 0.1× 6 310

Countries citing papers authored by V. R. Chandran

Since Specialization
Citations

This map shows the geographic impact of V. R. Chandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. R. Chandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. R. Chandran more than expected).

Fields of papers citing papers by V. R. Chandran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. R. Chandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. R. Chandran. The network helps show where V. R. Chandran may publish in the future.

Co-authorship network of co-authors of V. R. Chandran

This figure shows the co-authorship network connecting the top 25 collaborators of V. R. Chandran. A scholar is included among the top collaborators of V. R. Chandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. R. Chandran. V. R. Chandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kumar, Kota Arun, Célia R. S. Garcia, V. R. Chandran, et al.. (2007). Exposure of Plasmodium sporozoites to the intracellular concentration of potassium enhances infectivity and reduces cell passage activity. Molecular and Biochemical Parasitology. 156(1). 32–40. 50 indexed citations
2.
Tan, Eng‐King, Hui Shen, Jeanne M.M. Tan, et al.. (2005). Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease. Neurogenetics. 6(4). 179–184. 31 indexed citations
3.
Tan, Eng‐King, Stephanie Fook‐Chong, Kenneth Yew, et al.. (2005). Functional COMT variant predicts response to high dose pyridoxine in Parkinson's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 137B(1). 1–4. 21 indexed citations
4.
Tan, Eng‐King, Yongxiang Zhao, Hai‐Yang Law, et al.. (2004). Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology. 63(2). 362–363. 54 indexed citations
5.
Tan, Eng‐King, Yik‐Ying Teo, Yanping Zhao, et al.. (2004). Alpha-synuclein haplotypes implicated in risk of Parkinson’s disease. Neurology. 62(1). 128–131. 72 indexed citations
6.
Tan, Eng‐King, Yi Zhao, Kenneth Yew, et al.. (2004). Genetic analysis of DJ-1 in a cohort Parkinson’s disease patients of different ethnicity. Neuroscience Letters. 367(1). 109–112. 20 indexed citations
7.
Tan, Eng‐King, Henry Chung, V. R. Chandran, et al.. (2004). Nurr1 mutational screen in Parkinson's disease. Movement Disorders. 19(12). 1503–1505. 17 indexed citations
8.
Tan, Eng‐King, Celia Ia Choo Tan, Stephanie Fook‐Chong, et al.. (2003). Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. Journal of the Neurological Sciences. 216(1). 163–167. 138 indexed citations
9.
Tan, Eng-King, Henry Chung, Yi Zhao, et al.. (2003). Genetic analysis of Nurr1 haplotypes in Parkinson's disease. Neuroscience Letters. 347(3). 139–142. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026